These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25481975)

  • 1. Pharmacotherapy of Alzheimer's disease: current and future trends.
    Geldenhuys WJ; Darvesh AS
    Expert Rev Neurother; 2015 Jan; 15(1):3-5. PubMed ID: 25481975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current issues in dementia pharmacotherapy.
    Daiello LA
    Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current pharmacotherapy for Alzheimer's disease.
    Lleó A; Greenberg SM; Growdon JH
    Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Alzheimer's disease: current and future therapeutic approaches.
    Cummings JL
    Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost benefit to health plans of pharmacotherapy for Alzheimer's disease.
    Geldmacher DS
    Manag Care; 2005 Dec; 14(12):44-6, 49-52, 54-5. PubMed ID: 16405247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The present and future of pharmacotherapy of Alzheimer's disease: A comprehensive review.
    Anand A; Patience AA; Sharma N; Khurana N
    Eur J Pharmacol; 2017 Nov; 815():364-375. PubMed ID: 28978455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
    Li C; Ebrahimi A; Schluesener H
    Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and perspectives on the development of therapeutic agents for Alzheimer's disease].
    Hirouchi M
    Nihon Yakurigaku Zasshi; 2004 Jun; 123(6):421-7. PubMed ID: 15170082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
    Franke AG; Lieb K; Fellgiebel A
    Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future therapy in Alzheimer's disease.
    van Marum RJ
    Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy for Alzheimer's disease].
    Shoji M
    Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intended pharmacotherapeutical approaches of Alzheimer's disease therapy].
    Korábecný J; Hrubá E; Soukup O; Zemek F; Musílek K; Nepovímová E; Spilovská K; Opletalová V; Kuca K
    Ceska Slov Farm; 2012 Feb; 61(1-2):4-10. PubMed ID: 22536646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
    Tayeb HO; Yang HD; Price BH; Tarazi FI
    Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.